ACOG Alpha Cognition Inc.

Nasdaq www.alphacognition.com


$ 5.79 $ -0.08 (-1.37 %)    

Friday, 21-Nov-2025 15:46:36 EST
QQQ $ 590.60 $ 4.40 (0.75 %)
DIA $ 462.69 $ 5.05 (1.1 %)
SPY $ 659.19 $ 6.50 (1 %)
TLT $ 89.49 $ 0.27 (0.3 %)
GLD $ 373.59 $ -0.58 (-0.15 %)
$ 5.75
$ 5.83
$ 5.75 x 11
$ 5.84 x 1,015
$ 5.73 - $ 5.85
$ 3.75 - $ 11.54
46,657
na
95.69M
$ 0.31
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 11-13-2025 09-30-2025 10-Q
2 08-14-2025 06-30-2025 10-Q
3 05-15-2025 03-31-2025 10-Q
4 03-31-2025 12-31-2024 10-K
5 11-14-2024 09-30-2024 10-Q
6 08-12-2024 06-30-2024 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles

Alpha Cognition (NASDAQ:ACOG) reported quarterly sales of $2.300 million which beat the analyst consensus estimate of $2.033 mi...

Core News & Articles

HC Wainwright & Co. analyst Raghuram Selvaraju maintains Alpha Cognition (NASDAQ:ACOG) with a Buy and lowers the price t...

Core News & Articles

Alpha Cognition Inc. (NASDAQ:ACOG) ("Alpha Cognition" or the "Company"), a commercial-stage biopharmaceutical c...

Core News & Articles

Alpha Cognition Inc. (NASDAQ:ACOG), a commercial-stage biopharmaceutical company developing therapies for neurodegenerative dis...

Core News & Articles

Offering was led by an initial investment from a premier healthcare-dedicated investor alongside multiple large existing shareh...

Core News & Articles

Alpha Cognition Inc. (NASDAQ:ACOG) (the "Company"), a commercial-stage biopharmaceutical company dedicated to developin...

Core News & Articles

- SEC Filing

Core News & Articles

Alpha Cognition (NASDAQ:ACOG) reported quarterly losses of $(0.65) per share which missed the analyst consensus estimate of $(0...

Core News & Articles

Alpha Cognition Inc.

Core News & Articles

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Alpha Cognition (NASDAQ:ACOG) with a Buy and maintains $20 pri...

Core News & Articles

Alpha Cognition (NASDAQ:ACOG) reported quarterly losses of $(0.13) per share which beat the analyst consensus estimate of $(0.8...

Core News & Articles

Alpha Cognition Inc. (NASDAQ:ACOG) (the "Company" or "Alpha Cognition") today announced three upcoming presenta...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION